Registry Research and Medical Privacy
Authors:
- Julie R. IngelfingerJIJulie R. Ingelfinger
- Jeffrey M. DrazenJDJeffrey M. Drazen
- 1 April 2004
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (14) , 1452-1453
Abstract
Medical progress is possible largely because we learn from our successes and our failures. Researchers often make an assessment of where things stand for a given medical condition through disease registries that attempt to include everyone who has received a diagnosis of and been treated for a given condition in an institution, a region, or a nation. These critical data bases have been used to help us understand how care is delivered and the outcomes achieved. Sadly, around the world, data repositories are now at risk of significant bias because concern about privacy has led to the requirement that consent . . .Keywords
This publication has 3 references indexed in Scilit:
- Impracticability of Informed Consent in the Registry of the Canadian Stroke NetworkNew England Journal of Medicine, 2004
- Reasons for non-enrollment in a cohort study of ARF: the Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials networkAmerican Journal of Kidney Diseases, 2003
- Informed consent for cancer registrationThe Lancet Oncology, 2001